Adagene Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Adagene Stock Summary

Adagene competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, and Seres Therapeutics. Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company was incorporated in 2011 and is headquartered in Suzhou, China. Adagene Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 259 people.

Adagene Key Financial Ratios

Adagene Key Balance Sheet Accounts

Adagene Key Cash Accounts

Adagene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Adagene's current stock value. Our valuation model uses many indicators to compare Adagene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adagene competition to find correlations between indicators driving Adagene's intrinsic value. More Info.Adagene is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At this time, Adagene's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Adagene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Adagene Systematic Risk

Today, most investors in Adagene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Adagene's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Adagene growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Adagene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Adagene. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adagene based on widely used predictive technical indicators. In general, we focus on analyzing Adagene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adagene's daily price indicators and compare them against related drivers.

When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.